To include your compound in the COVID-19 Resource Center, submit it here.

Huntexil pridopidine: Phase II started

NeuroSearch began the open-label, North American Phase II Open HART trial to evaluate 45 mg

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE